Visionary Steve Jobs once said: “Those who are crazy enough to think they can change the world are the ones who do.” In Telangana, we embrace this ethos and seek to realize that life The impact that rapid advances in science and healthcare can have on billions of lives. We’re already making a real difference to patients around the world with products, services and ideas that originate in our state.
Telangana-based companies and institutions play an important role in life sciences manufacturing, contract R&D, medical technology innovation and Global Competence Centers (GCCs) that support high-end core activities of some of the largest life sciences companies in the world. As of January 2023, our life sciences ecosystem was valued at more than $80 billion, with a compound annual growth rate (CAGR) of more than 23% over the past two years, nearly twice the national average.
We expect to cross $100 billion by 2025, consolidating our position as India’s largest life sciences ecosystem. While we have revised our goal to $250 billion by 2030, our goal is to become the life sciences capital of the world within the next 10 years.
Telangana is home to more than 1,000 companies and is the only region in the world with more than 200 FDA-approved drug manufacturing sites. Hyderabad is known as the “vaccine capital of the world” and is responsible for producing one-third of the world’s vaccines. Notably, Hyderabad’s vaccine production capacity will surge from 9 billion doses to an impressive 14 billion doses by the end of 2024.
The city is also home to the booming Gene Valley, home to more than 200 life sciences companies, an emerging medical technology park with more than 55 device and diagnostics companies, and the upcoming Hyderabad Pharma City project, which is expected to become The largest project in the world.
The initiative taken by the Telangana government has attracted the participation of Novartis, Bristol-Myers Squibb, Roche, Sanofi, Bayer, Medtronic, Providence, Feline, Kemer, Sandoz, Advent, Syngene, Eurofins, Over $3 billion in new net investments in globally renowned companies such as Piramal, Jubilant, Sahajanand Medical Technologies, B-Braun, etc. in the past eight years. The life sciences sector in Telangana alone has created over 4.5 lakh jobs.
Going forward, we are determined to strengthen our global leadership in pharmaceuticals through Hyderabad Pharma City, which will be the world’s largest integrated pharmaceutical park. Excellent infrastructure, high standards yet low cost of living and world-class talent make us an ideal destination for high-end GCC and global innovation hubs. Established by globally recognized companies, these centers drive key functions such as research and development, analytics, innovation and engineering.
We recognize the transformative potential of technology to revolutionize healthcare, providing new possibilities for disease diagnosis and care delivery. Hyderabad already has cutting-edge technology hubs of well-known tech giants like Google, Amazon, Microsoft, Apple and others. Leveraging the engineering and product expertise of these multinational technology giants, we are poised to cultivate breakthrough healthcare solutions and grow globally recognized health technology unicorns.
In fact, our commitment to cutting-edge healthcare advancements is underlined by our partnership with the World Economic Forum (WEF) to establish the WEF’s first-ever Center for Life Sciences for the Fourth Industrial Revolution (C4IR) in Hyderabad.
Telangana has undoubtedly become one of the most renowned life sciences destinations in the world.
Rama Rao is the Telangana Industries and IT&EC Minister and Nagappan is the CEO of Telangana Lifesciences